ESPB Combined With Intercostal Nerve Block in VATs

Sponsor
Seoul National University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03949790
Collaborator
(none)
60
1
2
12.5
4.8

Study Details

Study Description

Brief Summary

A randomized prospective trial to test the effect of additional Erector Spinae Plane Block (ESPB) with intercostal nerve block during video assisted thoracoscopic surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: ESPB and Intercostal nerve block
  • Procedure: Intercostal nerve block
N/A

Detailed Description

A prospective randomized trial which aims to evaluate effect of peripheral nerve block for pain management, the Erector Spinae Plane Block (ESPB) in patients undergoing video assisted thoracoscopic surgery with intercostal nerve block.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Erector Spinae Plane Block Combined With Intercostal Nerve Block in Video Assisted Thoracoscopic Surgery: a Randomized Study
Actual Study Start Date :
Jun 18, 2019
Anticipated Primary Completion Date :
Jun 1, 2020
Anticipated Study Completion Date :
Jul 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Intercostal block with ESPB

Performed ESPB in VATs with intercostal nerve block

Procedure: ESPB and Intercostal nerve block
Erector spinae plane block + Intercostal nerve block

Active Comparator: Intercostal block without ESPB

Not Performed ESPB in VATs with intercostal nerve block

Procedure: Intercostal nerve block
Intercostal nerve block

Outcome Measures

Primary Outcome Measures

  1. Postoperative Pain [1 hour after surgery]

    VAS score (Visual Analog Scale for Pain, 0-10, higher value represent a worse outcome)

Secondary Outcome Measures

  1. Postoperative Pain [6 hours after surgery]

    VAS score (Visual Analog Scale for Pain, 0-10, higher value represent a worse outcome)

  2. Postoperative Pain [12 hours after surgery]

    VAS score (Visual Analog Scale for Pain, 0-10, higher value represent a worse outcome)

  3. Postoperative Pain [24 hours after surgery]

    VAS score (Visual Analog Scale for Pain, 0-10, higher value represent a worse outcome)

  4. Postoperative Pain [48 hours after surgery]

    VAS score (Visual Analog Scale for Pain, 0-10, higher value represent a worse outcome)

  5. Opioid consumption [postoperative 24 hours]

    cumulative total opioid consumption

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Wedge Resection or Lobectomy under VATS approach.
Exclusion Criteria:
  • Age < 20 years

  • Patients who has anatomical abnormality in any spine

  • Patients who has skin infection near to be the present procedure site

  • Intercostal nerve block is not performed during surgery

  • Previous lung surgery history of affected side

Contacts and Locations

Locations

Site City State Country Postal Code
1 SMG - SNU Boramae Medical Center Seoul Korea, Republic of 07061

Sponsors and Collaborators

  • Seoul National University Hospital

Investigators

  • Study Chair: Tae Kyong Kim, MD, phD, SMG-SNU Boramae

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Tae Kyong Kim, Assistant Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT03949790
Other Study ID Numbers:
  • 2019-107
First Posted:
May 14, 2019
Last Update Posted:
Sep 24, 2019
Last Verified:
Sep 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Sep 24, 2019